Molecular Diagnostics
Circulating Tumor DNA Detects Early Melanoma Growth
According to the National Cancer Institute, there were 91,270 new cases of melanoma in 2018, making up more than 5% of all new cancer cases. There were 9,320 estimated deaths in 2018, and 91.8% of patients survive five years or longer. More...11 Dec 2018
Methylation-Based Liquid Biopsy Test Detects Liver Cancer
Hepatocellular carcinoma (HCC) represents about 75% of liver cancers in the USA and already has well-established screening criteria focused largely on individuals with cirrhosis, who are screened every six months using ultrasound with or without blood testing for alpha- fetoprotein, according to guidelines. More...06 Dec 2018
Liquid Biopsy Detects Cancer across Multiple Biomarkers
Although biomarker-directed therapy is in its infancy in prostate cancer compared to some other tumor types, there is a great need for predictive biomarker testing, and great interest in noninvasive methods. However, comprehensive analysis of patients' cell-free DNA has been limited to date. More...06 Dec 2018
DNA Recombination in Brain Linked to Alzheimer's Disease
Alzheimer's disease is a public health crisis. The cause of the disease remains unknown and no meaningful treatment exists. Nearly six million people in the USA are living with Alzheimer's disease, a number projected to reach 14 million by 2060 as the population ages. More...05 Dec 2018
Genes Identified That Predispose People to Chronic Kidney Disease
Chronic kidney disease (CKD) affects 10% to 15% of the population worldwide and is now recognized as the most rapidly increasing contributor to global burden of disease. The costs related to CKD and end-stage renal disease (the terminal manifestation of CKD) are an enormous burden for all healthcare systems around the world. More...05 Dec 2018
LAMP Assay Validated for Visceral Leishmaniasis
Visceral leishmaniasis (VL) is one of the most neglected infectious diseases with an annual incidence of 50,000 to 90,000 new cases worldwide. Cases of VL are characterized by irregular bouts of fever, weight loss, hepatosplenomegaly, hypergammaglobulinemia, pancytopenia and anaemia. More...03 Dec 2018
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
In Other News
Highly Multiplexed Broad Pathogen Assay Detects Infectious Diseases
Acute Myeloid Leukemia Regulatory Networks Identified
Pregnancy-Related Immune Changes Revealed by Placenta Sequencing
Sensitive Tumor Detection Uses Cell-Free DNA Methylomes
Biomarker Found for Prostate Cancer Treatment Response
Recognized Cause of Pediatric Mitochondrial Disease Found
Ovarian Cancer Test Measures Biomarker Serum Levels
Childhood Epilepsy Diagnoses Shift with Genomic Reinterpretation
Cell-Free DNA Sequencing Test for Infectious Disease Analyzed
Genetic Basis of Childhood-Onset Cardiomyopathies Identified
Potential Brain Tumor Liquid Biopsies Developed
Microsatellite Instability Assay Validated for Cancer Studies
Genetic Test Helps Patients Avoid Unnecessary Thyroid Surgery
Herpes Simplex Virus Assay, Sample-to-Answer Instrument Get FDA Clearance
Breast Cancer Risk Variant Type Determines Tumor Aggressiveness
RNA Defects Linked to Multiple Myeloma Progression
Blood Compatibility Assay Approved by FDA
Blood Test Identifies Heart Failure with Preserved Ejection Fraction
Spinal Fluid Fingerprint Distinguishes Brain Infections from Diseases
Combined DNA Technologies Analyzed for Malaria Diagnosis
Warfarin Bleeding Risk SNPs Identified in African Americans
HPV DNA Test Monitors Remission in Oral Cancer
Ultrasensitive Screening Platform Detects Pathogenic Bacteria
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
